NASDAQ Capital Marke • Healthcare • Medical - Diagnostics & Research • AU • USD
Genetic Technologies Limited (GENE) has a consensus analyst rating of Sell, based on 1 analyst covering the stock. Of those, 0 recommend buying, 0 recommend holding, and 1 recommend selling.
No price target data available.
Be the first to know when stocks drop below their intrinsic value.
